Reporting Outcomes Per Surgeon Tied to Drop in CRC Sx Mortality

Share this content:
Reporting Outcomes Per Surgeon Tied to Drop in CRC Sx Mortality
Reporting Outcomes Per Surgeon Tied to Drop in CRC Sx Mortality

THURSDAY, May 3, 2018 (HealthDay News) -- The introduction of public reporting of surgeon specific 90-day postoperative mortality in elective colorectal cancer surgery is associated with a reduction in observed 90-day mortality, according to a study published online May 2 in The BMJ.

Abigail E. Vallance, M.B.B.S., from the Royal College of Surgeons of England in London, and colleagues examined the effect of surgeon specific outcome reporting in colorectal cancer surgery. Data were included for 111,431 patients diagnosed with colorectal cancer from April 1, 2011, to March 31, 2015.

The researchers found that there was no change in the proportion of patients with colorectal cancer undergoing major resection after introduction of surgeon specific public outcome reporting (63.3 percent before versus 63.2 percent after; P = 0.8). There was also no change in the proportion of these major resections categorized as elective or scheduled (84.5 versus 84.4 percent; P = 0.5). There was no change in the predicted 90-day mortality (2.7 versus 2.7 percent; P = 0.3), but there was a decrease in the observed 90-day mortality (2.8 versus 2.1 percent). This reduction was above the existing downward trend in mortality that was seen before public outcome reporting (P = 0.03).

"Public reporting of outcomes for individual clinicians seems to have triggered an improvement in outcomes after elective procedures," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »